A 7-gene biosignature for ductal carcinoma in situ of the breast identifies subpopulations of HER2-positive patients with distinct recurrence rates after breast-conserving surgery and radiation therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A 7-gene biosignature for ductal carcinoma in situ of the breast identifies subpopulations of HER2-positive patients with distinct recurrence rates after breast-conserving surgery and radiation therapy

Published:2024-09 Issue: Volume: Page:
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Vicini Frank,Shah Chirag,Mittal Karuna,Abraham Jame,Kruse Megan,Weinmann Sheila,Leo Michael,Rabinovitch Rachel,Wärnberg Fredrik,Whitworth Pat W.,Czerniecki Brian J.,Shivers Steven C.,Bremer Troy

Publisher

Elsevier BV

Reference26 articles.

1. Cancer Statistics;Siegel;CA Cancer J Clin,2021

2. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast;Early Breast Cancer Trialists' Collaborative;J Natl Cancer Inst Monogr,2010

3. A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk;Bremer;Clin Cancer Res,2018

4. Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy;Weinmann;Clin Cancer Res,2020

5. Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study;Solin;J Clin Oncol,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP